Aldiss, Peter
Nielsen, Malte Hasle
Burm, Hayley
Oró, Denise
Hansen, Henrik H.
Feigh, Michael
Gillum, Matthew P.
Funding for this research was provided by:
Danish Diabetes and Endocrine Academy (PD005-20)
Innovationsfonden (0153-00178B)
Novo Nordisk Fonden (NNF18CC0034900)
Article History
Received: 10 June 2024
Accepted: 7 April 2025
First Online: 28 May 2025
Competing interests
: M. H. Nielsen, D. Oró, H. H. Hansen, and M. Feigh are employed by Gubra. M. P. Gillum is employed by Novo Nordisk. None of the other authors has any conflicts of interest, financial or otherwise, to disclose.